BioNTech SE - ADR vs Gigacloud Technology Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Gigacloud Technology Inc trades at $52 (market cap $1.84B). The key difference: BioNTech SE - ADR is far larger — about 12.7× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | GCT | |
|---|---|---|
Market Cap | $23.31B | $1.84B |
Sector | Health | Technology |
52-Week High | $119.34 | $53.25 |
52-Week Low | $83.89 | $25.44 |
Enterprise Value | $6.60B | $1.97B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →